Member Info for SneakySimon

I am looking forward to:
- learning the value of the Surescreen revenue - I am setting a min of £10m
- learning some more about the DAM contract
- updates on the approvals ( I would be happier with getting at least 1 under our belt prior to 25thNov!)

But agree this could be a painful meeting if its just 'waiting for approvals' and 'its all coming'

you have to apply for professional test and then self test in the US...........

Lets hope so as the SP has momemntum to the downside - I remain invested as I believe the research I have done but at the same time, have some concerns about what is happening and the speed - its November and over halfway through a 'transformational year' - the DHSC contract has not started churning out tests and currently we can only sell our test professionally into Europe.

We have a lot in place that are positive - DAM contract (dependent on test approval) DHSC contract (dependent on test approval it would seem) - being realisitc, it is not a given that the approvals will pass? Thats not deramping, that is healthy risk managament. We have not had a great record with approvals in the past - ABC-19 waiting for home use approval - never came / Mologic antigen test failed at PD in Q1 2021.

AVCT have Medusa don't they - they seem pretty solid?

Some good analysis again by Shredz - so stage 7 of 9 - getting close to the business end of things - been a long slog but maybe some light at the end of the tunnel?

Not sure if it was the BBI news from the GLP or the GDR update highlighting another covid stock that has failed to deliver despite mighty promises - mainly due to

Need something at ODX to start moving soon around approvals, been patient but patience is starting to wear thin as the SP continues to under perform.

SP does not seem to share your excitement.

Guy claims he called Medusa and they spilled loads of info about loads of orders for when they get HUA..............I think as with ODX, best to wait for official news............

GDR was a bit more than that - they only got EUA in the states and as they stated, they could not convince companies to buy an EUA when they could buy a fully approved system.

GDR and ODX are a long way apart. We have two Covid related deals as well as deals related to CD4 - very different kettle of fish to GDR.

I was in and out of GDR trading it a bit - but the alarm bells were their tbh

Not sure I could cope not looking at the SP at least every 30 mins and being glued to Twitter / LSE!!

Have a good holiday - hopefully lots of glorious positive news!!

I think the ABC-19 was kyboshed because the vaccines were so plentiful - UKGOV bought something like 8 vaccines per person.

Think the other issue was with the tests showing antibodies but unknown levels and as we know, they wane over time so their would be a risk it was telling someone they were safe when in fact, they were not.

Fact is, GAD are also not manufacturing a govt test yet so the blame can’t be laid at Colin’s door.

I assume the Mologic test was ‘the chosen one’ but failed at Porton Down and 6 months later, we still have no approval for the test.

Frustrating we have not been doing another test in the interim - Surescreen has helped but I am sure not the massive revenue we could have been earning.

Maybe its too early on a Sunday but where does it state that the study is Surescreen?

“his going to tank the same way AVCT and GDR are…”

In the case of GDR they have a PCR test they can’t seem to get approved. The CEO had lots of hints of contracts ‘European country / US military / India’ but all of these never came to anything. The ear product looks good but can’t support the MCAP GDR had end last year.

AVCT had a MCAP of £800m at one point based on the opp of the LFT test - similar to GDR, lots of promises either from the

The things you mentioned in your post are in play - we have a DHSC contract, we have a CD4 business, a private contract with DAM, the Mologic test has been independtly reviewed and always came out very well (Europe and US) and Mologic are well connected. The Mologic test failing ar Porton Down was the spanner in the works - would be a hugely differnt story had it passed - hopefully that will change soon and we can see more about what is happening - I am interested in the capacity which I assume is greater than 2m pw

Like many, frustrated with the time and the lack of comms but it feels like we are closer - get the approvals and bingo.

I disagree - Mologic are in their too and are well connected and respected so not worried - the approvals will just take a while to come...........

that arrest of the Pfizer CEO arrest is fake!

£15 per test would mean DAM have only taken 50k tests which sounds low for an initial order given they were using 200k per month - appreciate they have Hughes LFT already but I would expect a larger number ordered?

It is very ironic that we sign a supply deal then immediately announce they can't actually sell the test because we need UK approval!

Its ok, Colin mentioned a dividend back at the start of the year - that divi may pay for hair replacement after I have pulled it all out!!!

Drop was the fact we are now not able to sell our test in the UK and unknown time for approval to come (if at all).

BIVDA article mentions up to weeks to get approval.

ODX always drops the most due partly poor sentiment as well as mo II so all in the hands of PI's who buy and sell more actively.

Disappointed? yes
Frustrated? yes
Tempted to sell after 18 months? yes

But I keep the faith, but like many other LTH, my frustration with the company is growing.

Share is getting yet another spanking as we are now awaiting yet another approval.

Approvals so far have not exactly gone swimmingly
- Home Use for ABC-19 - never materialised
- Mologic test - failed Porton Down (obv that is Mologic but impacts us)
- European HUA - appears to be delayed vs the anticipated timeline
- waiting on US professional usage - again, been a long time coming

So throwing a curve ball of the UK approval now needed makes some jittery - we have no idea as to how long this will take..........

Frustrating? Yes. Especially after Monday appeared like it was finally starting to get going and things were happening.

Exclusivity is only on the professional use test - ie not the Home Use Test (once approved)

Are you saying that Omega should not have used them because they had previously used the Hughes test? The Hughes test that is approved by the UKGOV? That is the dumbest arguement - does that apply to the UKGOV? Should we refuse to sell to them also?

Fact is, most avg punters don't care which test is used as long as it is legally approved and can get them on holiday etc.